Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Clinical trial NCT00247663 · COMPLETED

Trial details

NCT number: NCT00247663
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postmenopausal Women With Advanced Breast Cancer

Start date: 1999-12-01
Primary completion: 2005-12-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.